Patent ID: 6040334
Filing Date: 2000-03-21
Classification: A61K,A61P

Abstract:
A method for treating an adenocarcinoma selected from the group consisting of an adenocarcinoma of the prostate, an adenocarcinoma of the breast, an adenocarcinoma of the stomach, a pulmonary adenocarcinoma, and an adenocarcinoma of the colon in a mammal, comprising oral administration of an effective amount of a compound of the formula I ##STR3## wherein R.sub.1 is selected from a group consisting of a hydrogen atom, a hydroxy group, a 2-methylbutyryloxy group (--OCOCH(CH.sub.3)CH.sub.2 CH.sub.3) and a 2,2-dimethylbutyryloxy group (--OCOC(CH.sub.3)2CH.sub.2 CH.sub.3) and R.sub.2 is selected from a group consisting of a hydrogen atom and a methyl group.